Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 Mar 4;15(3):e088556.
doi: 10.1136/bmjopen-2024-088556.

Patients' acceptability, adherence and satisfaction on the modified shorter all-oral multidrug-resistant tuberculosis regimen: a two-phase cross-sectional study in Tanzania

Affiliations
Observational Study

Patients' acceptability, adherence and satisfaction on the modified shorter all-oral multidrug-resistant tuberculosis regimen: a two-phase cross-sectional study in Tanzania

Julieth Lalashowi et al. BMJ Open. .

Abstract

Objectives: To determine patients' acceptability, satisfaction and adherence to shorter all-oral multidrug-resistant tuberculosis (MDR-TB) regimen in Tanzania.

Design: A two-phase cross-sectional study with data collected within 6 months of Removed Injectable modified Short-course regimens for EXpert MDR-TB (RISE) study implementation and the second phase within 15 months of implementation using the same reference populations.

Settings: 18 health facilities across eight regions of Tanzania.

Participants: Rifampicin-resistant TB/MDR-TB patients enrolled in the RISE study.

Outcome measures: We assessed patients' acceptability, adherence and satisfaction with the regimen using an interval scale structured questionnaire.

Results: The majority of the patients found the shorter oral MDR-TB treatment acceptable, adhered to it well and were generally satisfied. The median score (IQR) for acceptability was 1.7 (1.03-2.00) but it ranged between 1.3 (1.3-2) and 1.7 (1-1.79) for the first and second phases, respectively. Regarding adherence, the median score (IQR) stood at 4 (3.67-4.67) with scores significantly higher in the second phase at 4.33 (4.00-5.007) compared with the first at 4.67 (4.00-5.0), p value=0.01. The overall satisfaction was high at 1.5 (1.33-1.78) but it ranged between 1.22 (1.00-1.78) and 1.42 (1.11-1.78) for the first and second phases, respectively. Worrying about side effects was statistically associated with adherence (p value<0.05). No statistically significant associations were found for acceptability and satisfaction.

Conclusion: Generally, the modified shorter oral MDR-TB regimen was accepted, and patients reported good adherence and were satisfied. More engagement with patients could provide more insights into factors that can maximise acceptability, adherence and satisfaction with the regimen.

Keywords: Medication Adherence; Patient Satisfaction; Tuberculosis.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Bastos ML, Lan Z, Menzies D. An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis. Eur Respir J. 2017;49:1600803. doi: 10.1183/13993003.00803-2016. - DOI - PubMed
    1. World Health Organization WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, Online Annexes WHO Rep Geneva. 2020. - PubMed
    1. World Health Organization Global Tuberculosis Report. 2021.
    1. Ministry of Health CDGE and C Manual for management of Tuberculosis and Leprosy in Tanzania, 7th edition. 2020.
    1. Zhang M-W, Zhou L, Zhang Y, et al. Treatment outcomes of patients with multidrug and extensively drug-resistant tuberculosis in Zhejiang, China. Eur J Med Res. 2021;26:31.:31. doi: 10.1186/s40001-021-00502-0. - DOI - PMC - PubMed

Publication types

Substances

LinkOut - more resources